CIK 0001787740 · <br>Emerging growth company
Valion Bio, Inc.
Sign in to watch- Ticker
- VBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814016391
- Phone
- (888)276-6888
- Business address
- 1305 E. HOUSTON STREET, BUILDING 1, SUITE 311, SAN ANTONIO, TX, 78205
- Former names
- Tivic Health Systems, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-04 | Gurfein Blake Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2021-12-14 | Drexler Karen Director | Grant or award · Employee Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-12-14 | Gurfein Blake Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +82,500 | 82,500 | ||
| 2021-12-14 | Zikria Dean Director | Grant or award · Employee Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-12-14 | Sabia Ryan VP of Sales and Operations | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-12-14 | Bolton Sheryle Director | Grant or award · Employee Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2021-11-12 | Ernst Jennifer Chief Executive Officer | Conversion | +1,391 | 1,172,891 | ||
| 2021-11-12 | Ernst Jennifer Chief Executive Officer | Conversion | +26,986 | 1,199,877 | ||
| 2021-11-12 | Ernst Jennifer Chief Executive Officer | Conversion · Series Seed-2 Convertible Preferred Stock | −5,566 | 0 | ||
| 2021-11-12 | Ernst Jennifer Chief Executive Officer | Conversion · Convertible Promissory Note | −0 | 0 |
Page 4 of 4 · 70 trades